National Workshop on Good Clinical Practice (GCP) 2025

Date:

Share post:

National Workshop on Good Clinical Practice (GCP) 2025

Date: 02.08.2025

Time: 9.30 AM – 4.30 PM

Venue: K. P. BASU Memorial Hall, Jadavpur University (Offline)

Online : Online Live Streaming(Google Meet)  

Organized By :
PharmaGenDRx & ABS Clinical Solutions
In Association With : Bioequivalence Study Centre, Jadavpur University

 

    • Keynote Speakers:
    • Prof. (Dr.) Suparna Chatterjee, Dept. of Pharmacology, IPGMER Kolkata
    • Prof. (Dr.) Avijit Hazra, Dean of Student Affairs, IPGMER-SSKM Hospital
    • Dr. Supriyo Chowdhury, Asst. Director Research, Institute of Neurosciences, Kolkata
    • Prof. (Dr.) Arunava Biswas, MD,DM,HOD Barasat Medical College & Hospital

  •  

  •  

REGISTRATION DETAILS :
For Offline Attendees-
Student – Rs. 799 (Early Bird Registration till 5th July, 2025)
  Rs. 899  (Final Registration)
Academia & Industry –  Rs.1199 (Early Bird Registration till 5th July, 2025)
Rs. 1299 (Final Registration)

For Online Attendees –
Student – Rs. 499 (Early Bird Registration till 5th July, 2025)
  Rs. 599  (Final Registration)
Academia & Industry –  Rs. 799 (Early Bird Registration till 5th July, 2025)
Rs. 899 (Final Registration)


Each Participants will get Certificate for Participation from Jadavpur University Bioequivalence Study Centre.
Offline Participants will be provided with breakfast, lunch, and tea during the workshop.  
Registration fees are non-refundable.

 

Registration Here : https://docs.google.com/forms/d/18DbD6nv1T_TeLqB3lm6M6ewXfTLKC16tixZKCv5Y40g/viewform?edit_requested=true

Digital Media Partners : PharmaTutor, Being Pharmacist, Pharmacist Tanyeem

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...